Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeinol and Mild Hypothermia in Acute Ischemic Stroke
NCT00299416Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Feb 2003
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of caffeine and ethanol in ischemic stroke, sponsored by UTHealth Houston. Primary endpoints: Number of Participants With Symptomatic Intracerebral Hemorrhage at 90 days, Number of Participants With Catheter Related Complications During Hypothermia & Rewarming at 36 hours and 1 more. Started Feb 2003; status: completed.
02
Drugs
caffeineethanol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00299416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299416.